rifamycin SV

Valeant partner Cosmo turns wannabe IBS-D rival, and it could do some sales damage: analyst
Fierce Pharma
Mon, 01/29/18 - 11:57 pm
Valeant Pharmaceuticals
Cosmo Pharma
rifamycin SV
IBS-d
Xifaxan